Cutaneous larva migrans (CLM), a skin infection caused by the larvae of hookworms, is typically associated with tropical and subtropical regions. However, increasing international travel means cases are being diagnosed in temperate climates, including among travelers returning from endemic areas. A recent case report details an instance of imported CLM in an adolescent traveler, highlighting the importance of considering travel history when diagnosing unusual skin conditions.
The case, documented in a report, involved a 15-year-traditional male who presented with intensely itchy, serpiginous (snake-like) skin lesions on his feet and legs. The symptoms began approximately two weeks after returning from a trip to an area where hookworm infection is prevalent. Initial examination ruled out other common causes of skin rashes, prompting clinicians to investigate potential parasitic infections. CLM is often misdiagnosed initially, emphasizing the necessitate for awareness among healthcare professionals.
The diagnosis of CLM is primarily clinical, based on the characteristic appearance of the lesions and a relevant travel history. According to the Pan American Health Organization (PAHO), the diagnosis is “easily made clinically” when combined with information about recent travel or residence in an endemic area . In this case, the adolescent’s recent travel history was a key factor in considering CLM as a possible diagnosis. Laboratory confirmation, while possible, is not always necessary for diagnosis.
Hookworm larvae typically enter the skin when individuals walk barefoot on contaminated sand or soil. The larvae cannot penetrate intact skin, so wearing shoes provides a protective barrier. The larvae migrate just beneath the skin surface, causing intense itching and a visible, winding rash. The lesions are not contagious, meaning they cannot be spread from person to person. The condition is generally self-limiting, meaning it will eventually resolve on its own as the larvae die, but treatment can significantly reduce symptoms and speed up recovery.
Treatment for CLM typically involves oral anti-parasitic medications, such as albendazole or ivermectin. These medications effectively kill the larvae, relieving the itching and allowing the skin to heal. According to research published in 2013, cutaneous larva migrans was one of the most commonly reported epidermal parasitic skin diseases in returned travelers . The GeoSentinel Surveillance Network, which monitors illness in returned travelers, reported 806 cases of cutaneous larva migrans between 2007 and 2011.
The case report underscores the increasing importance of considering imported infectious diseases in travelers. Globalization and increased travel have led to a rise in the number of cases of diseases previously confined to specific geographic regions being diagnosed in non-endemic areas. Clinicians must be vigilant in obtaining detailed travel histories from patients presenting with unusual symptoms.
Further research is needed to better understand the global distribution of CLM and to develop more effective prevention strategies. Public health initiatives aimed at educating travelers about the risks of hookworm infection and the importance of wearing shoes in endemic areas could help reduce the incidence of this preventable condition. Continued surveillance of imported infectious diseases is crucial for protecting public health.
Disclaimer: This information is for general knowledge and informational purposes only, and does not constitute medical advice. We see essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Have you or someone you know experienced a similar travel-related illness? Share your thoughts and experiences in the comments below.
